InsiderTrades

Atlas Venture Associates Opportunity I, L.P.

SEC CIK 1780065 · EDGAR

Buying vs selling by month open-market trades, last 47 months, all 3 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
XLOXilio Therapeutics, Inc.10% 2.02M — $3,600 22024-01-112024-01-11
IRONDisc Medicine, Inc.10% 1.45M — $22.05M 42023-08-142024-01-10
KYMRKymera Therapeutics, Inc.10% 1.00M — $6.60M 22022-11-022022-11-02

Most active insiders at XLO, 12 months

#InsiderTitleBoughtSold
1 Shannon James SamuelDir $43.9K—
2 Frankenfield Christopher JamesCFO —$4,499
3 Brennan Kevin M.SVP, Fin AND ACCOUNTING —$1,169
4 Luptakova KatarinaChief MEDICAL Off ——
5 Russo RenePres AND CEO, Dir ——

Atlas Venture Associates Opportunity I, L.P. made no open-market trades at XLO in the last 12 months.

Transactions 8

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
M 2024-01-16 2024-01-11+ XLO Xilio Therapeutics, Inc. Atlas Venture Associates Opportunity I, L.P. 10% S - Sale $0.8502 -3,106 2.02M -0.2% -$2,641
MI 2024-01-16 2024-01-11+ XLO Xilio Therapeutics, Inc. Atlas Venture Associates Opportunity I, L.P. 10% S - Sale $0.8502 -1,129 734.8K -0.2% -$959.83
2024-01-12 2024-01-10 IRON Disc Medicine, Inc. Atlas Venture Associates Opportunity I, L.P. 10% S - Sale $64.00 -30.0K 1.45M -2% -$1.92M
I 2024-01-12 2024-01-10 IRON Disc Medicine, Inc. Atlas Venture Associates Opportunity I, L.P. 10% S - Sale $64.00 -20.0K 786.2K -2% -$1.28M
M 2023-08-16 2023-08-14+ IRON Disc Medicine, Inc. Atlas Venture Associates Opportunity I, L.P. 10% S - Sale $52.52 -286.1K 2.06M -12% -$15.02M
I 2023-08-16 2023-08-15 IRON Disc Medicine, Inc. Atlas Venture Associates Opportunity I, L.P. 10% S - Sale $52.40 -72.9K 882.2K -8% -$3.82M
MI 2022-11-04 2022-11-02+ KYMR Kymera Therapeutics, Inc. Atlas Venture Associates Opportunity I, L.P. 10% S - Sale $30.01 -48.1K 1.00M -5% -$1.44M
M 2022-11-04 2022-11-02+ KYMR Kymera Therapeutics, Inc. Atlas Venture Associates Opportunity I, L.P. 10% S - Sale $30.01 -171.9K 5.44M -3% -$5.16M

Purchase Sale Sale after option exercise All abbreviations